Enhanced Ozonized Olive Oil Compositions for Vulvovaginitis Treatment and Prevention

Publication ID: 24-11857570_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Ozonized Olive Oil Compositions for Vulvovaginitis Treatment and Prevention,” Published Technical Disclosure No. 24-11857570_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857570_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,570.

Summary of the Inventive Concept

Improved ozonized olive oil compositions with synergistic blends of natural extracts for more effective treatment and prevention of vulvovaginitis, addressing the limitations of existing compositions.

Background and Problem Solved

Vulvovaginitis is a common and recurring problem for women, and current treatments often have limitations. The original patent disclosed ozonized olive oil compositions with natural extracts, but these compositions may not provide optimal efficacy. The new inventive concept addresses this limitation by introducing synergistic blends of natural extracts, enhancing the treatment and prevention of vulvovaginitis.

Detailed Description of the Inventive Concept

The new inventive concept comprises ozonized olive oil compositions with a peroxide value of 50-350 mEq O2/Kg, further enriched with synergistic blends of at least three liquid vegetable extracts selected from among Allium spp., Aloe spp., Calendula officinalis, and Thymus spp. These blends provide enhanced antimicrobial and anti-inflammatory properties, improving the treatment and prevention of vulvovaginitis. The compositions can be formulated as ointments, creams, gels, or foams, and may be packaged in single-use applicators or kits with instructions for use.

Novelty and Inventive Step

The new claims introduce novel synergistic blends of natural extracts, which provide unexpected improvements in efficacy and safety compared to the original patent. The inventive step lies in the discovery of these synergistic blends and their application in ozonized olive oil compositions.

Alternative Embodiments and Variations

Alternative embodiments may include varying the ratio of ozonized olive oil to natural extracts, using different types of natural extracts, or incorporating additional ingredients to enhance the compositions' properties. Variations may also include different formulations, such as suppositories or vaginal tablets, or different packaging options.

Potential Commercial Applications and Market

The enhanced ozonized olive oil compositions have significant commercial potential in the gynecology and women's health markets, offering a natural, safe, and effective solution for vulvovaginitis treatment and prevention. The market potential includes over-the-counter and prescription products, as well as opportunities for partnerships with healthcare providers and women's health organizations.

Field of Art

Pharmaceutical and cosmetic compositions for topical treatment of gynecological infections, with expertise in natural extract formulations, ozonization techniques, and antimicrobial compositions

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced training in pharmaceutical sciences, organic chemistry, or botanical medicine, possessing knowledge of natural extract preparation, antimicrobial composition design, and topical drug delivery systems

Obviousness Rationale

A PHOSITA would recognize that expanding the natural extract combinations in ozonized olive oil compositions represents a predictable variation of the source patent's core invention. The technical framework established by US 11857570 provides clear guidance for exploring additional natural extracts with known antimicrobial properties. The systematic approach of combining vegetable extracts with ozonized olive oil follows established pharmaceutical development strategies for enhancing therapeutic efficacy.

Obvious Combinations & Variations

Source Patent Element
Ozonized olive oil composition with Calendula officinalis and Melaleuca spp. extracts
PTD Variation
Adding Allium spp., Aloe spp., and Thymus spp. as additional natural extracts
Obviousness Reasoning
Known botanical extracts with established antimicrobial properties that would be predictably combinable by a PHOSITA seeking enhanced therapeutic effectiveness
Source Patent Element
Topical treatment formulation for vulvovaginitis
PTD Variation
Introducing single-use applicators and treatment kits
Obviousness Reasoning
Standard pharmaceutical packaging design representing an obvious design choice for improving patient convenience and product usability
Source Patent Element
Peroxide value range of 50-350 mEq O2/Kg
PTD Variation
Exploring alternative natural extract combinations within the same peroxide value range
Obviousness Reasoning
Routine experimentation within established compositional parameters to optimize antimicrobial and therapeutic properties
Source Patent Element
Ointment, cream, gel, and foam formulations
PTD Variation
Adding suppository and vaginal tablet formulations
Obviousness Reasoning
Predictable extension of existing dosage forms using standard pharmaceutical compounding techniques
Source Patent Element
Natural extract-based antimicrobial composition
PTD Variation
Incorporating extracts from Curcuma spp., Plantago spp., Cinnamomum spp., and Salvia officinalis
Obviousness Reasoning
Systematic exploration of known botanical extracts with documented antimicrobial properties represents an obvious variation to a PHOSITA
35 U.S.C. § 103 Summary: Based on the teachings of US 11857570, the present publication demonstrates that the variations in natural extract combinations, formulation techniques, and delivery methods for ozonized olive oil compositions would have been obvious to a person having ordinary skill in the art at the time of invention. The systematic exploration of botanical extracts and pharmaceutical formulations represents a predictable extension of the prior art, rendering potential patent claims obvious and anticipatable.

Original Patent Information

Patent NumberUS 11,857,570
TitleNatural composition for use in gynecology
Assignee(s)ORGANICARE LLC